Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo

Marilyn S. Bartlett, William L. Current, Michael P. Goheen, Carole J. Boylan, Chao-Hung Lee, Margaret M. Shaw, Sherry Queener, James W. Smith

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Cyclic lipodepsipeptide compounds of the echinocandin class exhibit broad-spectrum antifungal activity and have been shown to be effective in the treatment of Pneumocystis carinii pneumonia in laboratory animal models. Previous studies have led investigators to propose that these compounds, active against fungal cell walls, are selectively active against the cyst forms of P. carinii. We demonstrate that a semisynthetic, water-soluble echinocandin analog, LY307853, is effective in reducing the numbers of all life cycle forms of P. carinii and is more effective in mice immunosuppressed with monoclonal antibody to L3T4+ cells than in mice immunosuppressed with dexamethasone. Treatment of P. carinii isolates with LY307853 in a short- term in vitro culture model resulted in cytoarchitectural alterations suggesting that this echinocandin may interfere with the export of surface glycoprotein and the formation of the tubular elements normally found on the surfaces of trophic forms. The cytoarchitectural changes in trophic forms treated in vitro with LY307853 were also observed in trophic forms in the lung tissue of rats treated with a closely related echinocandin analog, LY303366.

Original languageEnglish
Pages (from-to)1811-1816
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume40
Issue number8
StatePublished - Aug 1996

Fingerprint

Echinocandins
Pneumocystis carinii
Cell Wall
anidulafungin
Pneumocystis Pneumonia
Membrane Glycoproteins
Life Cycle Stages
Dexamethasone
Cysts
Animal Models
Monoclonal Antibodies
Research Personnel
Lung
In Vitro Techniques
Water

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Bartlett, M. S., Current, W. L., Goheen, M. P., Boylan, C. J., Lee, C-H., Shaw, M. M., ... Smith, J. W. (1996). Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrobial Agents and Chemotherapy, 40(8), 1811-1816.

Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. / Bartlett, Marilyn S.; Current, William L.; Goheen, Michael P.; Boylan, Carole J.; Lee, Chao-Hung; Shaw, Margaret M.; Queener, Sherry; Smith, James W.

In: Antimicrobial Agents and Chemotherapy, Vol. 40, No. 8, 08.1996, p. 1811-1816.

Research output: Contribution to journalArticle

Bartlett, MS, Current, WL, Goheen, MP, Boylan, CJ, Lee, C-H, Shaw, MM, Queener, S & Smith, JW 1996, 'Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo', Antimicrobial Agents and Chemotherapy, vol. 40, no. 8, pp. 1811-1816.
Bartlett MS, Current WL, Goheen MP, Boylan CJ, Lee C-H, Shaw MM et al. Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 1996 Aug;40(8):1811-1816.
Bartlett, Marilyn S. ; Current, William L. ; Goheen, Michael P. ; Boylan, Carole J. ; Lee, Chao-Hung ; Shaw, Margaret M. ; Queener, Sherry ; Smith, James W. / Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. In: Antimicrobial Agents and Chemotherapy. 1996 ; Vol. 40, No. 8. pp. 1811-1816.
@article{a265beb9d6d04080a68e47f7ab479e7b,
title = "Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo",
abstract = "Cyclic lipodepsipeptide compounds of the echinocandin class exhibit broad-spectrum antifungal activity and have been shown to be effective in the treatment of Pneumocystis carinii pneumonia in laboratory animal models. Previous studies have led investigators to propose that these compounds, active against fungal cell walls, are selectively active against the cyst forms of P. carinii. We demonstrate that a semisynthetic, water-soluble echinocandin analog, LY307853, is effective in reducing the numbers of all life cycle forms of P. carinii and is more effective in mice immunosuppressed with monoclonal antibody to L3T4+ cells than in mice immunosuppressed with dexamethasone. Treatment of P. carinii isolates with LY307853 in a short- term in vitro culture model resulted in cytoarchitectural alterations suggesting that this echinocandin may interfere with the export of surface glycoprotein and the formation of the tubular elements normally found on the surfaces of trophic forms. The cytoarchitectural changes in trophic forms treated in vitro with LY307853 were also observed in trophic forms in the lung tissue of rats treated with a closely related echinocandin analog, LY303366.",
author = "Bartlett, {Marilyn S.} and Current, {William L.} and Goheen, {Michael P.} and Boylan, {Carole J.} and Chao-Hung Lee and Shaw, {Margaret M.} and Sherry Queener and Smith, {James W.}",
year = "1996",
month = "8",
language = "English",
volume = "40",
pages = "1811--1816",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo

AU - Bartlett, Marilyn S.

AU - Current, William L.

AU - Goheen, Michael P.

AU - Boylan, Carole J.

AU - Lee, Chao-Hung

AU - Shaw, Margaret M.

AU - Queener, Sherry

AU - Smith, James W.

PY - 1996/8

Y1 - 1996/8

N2 - Cyclic lipodepsipeptide compounds of the echinocandin class exhibit broad-spectrum antifungal activity and have been shown to be effective in the treatment of Pneumocystis carinii pneumonia in laboratory animal models. Previous studies have led investigators to propose that these compounds, active against fungal cell walls, are selectively active against the cyst forms of P. carinii. We demonstrate that a semisynthetic, water-soluble echinocandin analog, LY307853, is effective in reducing the numbers of all life cycle forms of P. carinii and is more effective in mice immunosuppressed with monoclonal antibody to L3T4+ cells than in mice immunosuppressed with dexamethasone. Treatment of P. carinii isolates with LY307853 in a short- term in vitro culture model resulted in cytoarchitectural alterations suggesting that this echinocandin may interfere with the export of surface glycoprotein and the formation of the tubular elements normally found on the surfaces of trophic forms. The cytoarchitectural changes in trophic forms treated in vitro with LY307853 were also observed in trophic forms in the lung tissue of rats treated with a closely related echinocandin analog, LY303366.

AB - Cyclic lipodepsipeptide compounds of the echinocandin class exhibit broad-spectrum antifungal activity and have been shown to be effective in the treatment of Pneumocystis carinii pneumonia in laboratory animal models. Previous studies have led investigators to propose that these compounds, active against fungal cell walls, are selectively active against the cyst forms of P. carinii. We demonstrate that a semisynthetic, water-soluble echinocandin analog, LY307853, is effective in reducing the numbers of all life cycle forms of P. carinii and is more effective in mice immunosuppressed with monoclonal antibody to L3T4+ cells than in mice immunosuppressed with dexamethasone. Treatment of P. carinii isolates with LY307853 in a short- term in vitro culture model resulted in cytoarchitectural alterations suggesting that this echinocandin may interfere with the export of surface glycoprotein and the formation of the tubular elements normally found on the surfaces of trophic forms. The cytoarchitectural changes in trophic forms treated in vitro with LY307853 were also observed in trophic forms in the lung tissue of rats treated with a closely related echinocandin analog, LY303366.

UR - http://www.scopus.com/inward/record.url?scp=0029837527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029837527&partnerID=8YFLogxK

M3 - Article

C2 - 8843286

AN - SCOPUS:0029837527

VL - 40

SP - 1811

EP - 1816

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -